Kennon-Green & Company’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.03M Buy
12,732
+2,070
+19% +$199K 0.79% 28
2026
Q2
$1.02M Sell
10,662
-1,399
-12% -$134K 0.79% 30
2026
Q1
$1.25M Buy
12,061
+407
+3% +$46.1K 1.02% 24
2025
Q4
$1.18M Buy
11,654
+5,634
+94% +$612K 0.93% 26
2025
Q3
$742K Buy
6,020
+3,251
+117% +$404K 0.58% 32
2025
Q2
$342K Buy
2,769
+76
+3% +$10.1K 0.27% 36
2025
Q1
$397K Buy
2,693
+275
+11% +$42K 0.32% 37
2024
Q4
$393K Buy
2,418
+60
+3% +$9.81K 0.34% 38
2024
Q3
$384K Buy
2,358
+312
+15% +$46.2K 0.32% 38
2024
Q2
$279K Buy
2,046
+155
+8% +$21.5K 0.26% 39
2024
Q1
$290K Buy
1,891
+71
+4% +$10.6K 0.27% 39
2023
Q4
$260K Sell
1,820
-786
-30% -$105K 0.26% 39
2023
Q3
$342K Buy
2,606
+57
+2% +$8.66K 0.34% 39
2023
Q2
$405K Buy
2,549
+991
+64% +$160K 0.38% 37
2023
Q1
$247K Buy
1,558
+66
+4% +$9.9K 0.23% 42
2022
Q4
$209K Buy
+1,492
New +$212K 0.21% 44

Other funds holding CLX

Kennon-Green & Company's CLX Position: Q3 2026 in Review

Kennon-Green & Company increased its Clorox (CLX) stake by 19% in Q3 2026, buying an estimated $199K and bringing the position to 12,732 shares worth $1.03M. The position accounts for 0.79% of the portfolio, ranked #28.

Kennon-Green & Company first reported a position in CLX in Q4 2022 and has held it in 16 quarters since. The position peaked at $1.25M in Q1 2026. 15 funds tracked by Wall St. Rank hold CLX as of Q3 2026.

  • Kennon-Green & Company held 12,732 shares of Clorox worth $1.03M as of Q3 2026.
  • Kennon-Green & Company bought 2,070 Clorox shares in Q3 2026, an estimated $199K.
  • Clorox made up 0.79% of Kennon-Green & Company's portfolio in Q3 2026, its #28 holding.
  • Kennon-Green & Company first reported a position in Clorox in Q4 2022 and has held it in 16 quarters since.
  • Kennon-Green & Company's Clorox position peaked at $1.25M in Q1 2026.
  • 15 funds tracked by Wall St. Rank held Clorox as of Q3 2026.

Based on Kennon-Green & Company's 13F filing for Q3 2026, filed 5 Oct 2026.